Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2012
12/04/2012US8324380 Amino-heteroaryl-containing prokineticin 1 receptor antagonists
12/04/2012US8324379 Prodrugs of heteroaryl compounds
12/04/2012US8324375 Branched α-glucan, α-glucosyltransferase which forms the glucan, their preparation and uses
12/04/2012US8324373 Highly stereoselective process for preparing gemcitabine and intermediates thereof
12/04/2012US8324370 Interfering RNA molecules
12/04/2012US8324357 Universal fieldable assay with unassisted visual detection
12/04/2012US8324284 Migrastatin analogs and uses thereof
12/04/2012US8324283 Solid pharmaceutical compositions comprising a SIP receptor agonist and a sugar alcohol
12/04/2012US8324282 Alkylating agent combinations in the treatment of cancer
12/04/2012US8324281 Topical nepafenac formulations
12/04/2012US8324280 Treatment of prostate cancer with DDC inhibitor
12/04/2012US8324279 Compositions and methods for inhibiting an isoform of human manganese superoxide dismutase
12/04/2012US8324278 Amino acid based compositions for the treatment of pathological conditions distinguished by insufficient mitochondrial function
12/04/2012US8324277 Nitrated-fatty acids modulation of type II diabetes
12/04/2012US8324276 Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction
12/04/2012US8324275 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
12/04/2012US8324274 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
12/04/2012US8324273 Catechol protected levodopa diester prodrugs, compositions, and methods of use
12/04/2012US8324272 Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use
12/04/2012US8324271 Eye drop composition containing isopropyl unoprostone
12/04/2012US8324270 Methods for the treatment and prevention of age-related retinal dysfunction
12/04/2012US8324269 Stable compositions of dehydroascorbic acid
12/04/2012US8324268 Substituted furancarboxamides, and use thereof
12/04/2012US8324267 Kinase inhibitors and the use thereof
12/04/2012US8324266 Compositions, methods and systems for respiratory delivery of two or more active agents
12/04/2012US8324265 Heterocyclic compounds having type I 11β hydroxysteroid dehydrogenase inhibitory activity
12/04/2012US8324264 Inhibitors of bacterial biofilms and related methods
12/04/2012US8324262 Tricyclic necrostatin compounds
12/04/2012US8324261 Histidine derivatives
12/04/2012US8324260 Methods of treating pediatric patients using dexmedetomidine
12/04/2012US8324258 F1F0-ATPase inhibitors and related methods
12/04/2012US8324257 Mitotic kinesin inhibitors and methods of use thereof
12/04/2012US8324256 Tri-functional UV-absorbing compounds and use thereof
12/04/2012US8324255 Chelator stabilized cationic ammonium compounds and compositions comprising the same
12/04/2012US8324254 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (S1P) agonists
12/04/2012US8324252 e.g. 6-(5-Cyclopropyl-1H-pyrazol-3-ylamino)-5-fluoro-2-(1-(4-fluorophenyl)ethylamino) nicotinonitrile; tropomyosin-related kinases (Trk's) inhibitor; anticarcinogenic agent; hormone related cancer, leukemia; antiinflammatory agent; arthritis, restenosis; autoimmune diseases
12/04/2012US8324251 Cyclic modulators of chemokine receptor activity
12/04/2012US8324250 Piperidine derivatives as NK3 receptor antagonists
12/04/2012US8324249 Tetrahydropyridinyl and dihydropyrrolyl compounds and the use thereof
12/04/2012US8324248 Piperidine derivatives as NK3 receptor antagonists
12/04/2012US8324247 Method for treating pulmonary arterial hypertension
12/04/2012US8324246 Indol carboxylic acid bispyridyl carboxamide derivatives, pharmaceutically acceptable salt thereof, preparation method and composition containing the same as an active ingredient
12/04/2012US8324245 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same
12/04/2012US8324244 Process and intermediates for preparing integrase inhibitors
12/04/2012US8324243 Derivatives of the aminated hydroxyquinoline class for treating cancers
12/04/2012US8324242 Modulators of ATP-binding cassette transporters
12/04/2012US8324241 Triazolo compounds useful as DGAT1 inhibitors
12/04/2012US8324240 Fused amino pyridine as HSP90 inhibitors
12/04/2012US8324239 Furopyridine compounds and uses thereof
12/04/2012US8324238 Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza-spiro[3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same
12/04/2012US8324237 Methods for the treatment and prevention of inflammatory diseases
12/04/2012US8324235 Heterocyclic spiro-compounds
12/04/2012US8324232 4-pyrimidinesulfamide derivative
12/04/2012US8324231 Pyrimidinones as casein kinase II (CK2) modulators
12/04/2012US8324230 Kinase inhibitor; amtiinflammatory agents; rheumatic diseases; osteoarthritis; asthma
12/04/2012US8324229 Alkylthio pyrimidines as CRTH2 antagonists
12/04/2012US8324228 Pyrimidine classical cannabinoid compounds and related methods of use
12/04/2012US8324227 Thieno[2,3-D]-pyrimidin-4(3H)-one compounds with antifungal properties and process thereof
12/04/2012US8324226 Therapeutic oxy-phenyl-aryl compounds and their use
12/04/2012US8324225 Pyrrolopyrimidine compounds and their uses
12/04/2012US8324224 A2B adenosine receptor antagonists
12/04/2012US8324223 Substituted thieno [2,3-d] pyrimidines as HIV inhibitors
12/04/2012US8324222 Cyclically substituted furopyrimidine derivatives and use thereof
12/04/2012US8324221 Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
12/04/2012US8324220 Pyrimidines useful as modulators of voltage-gated ion channels
12/04/2012US8324219 Substituted benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
12/04/2012US8324218 Aliphatic pyrazinoylguanidine sodium channel blockers with beta agonist activity
12/04/2012US8324217 Cold menthol receptor antagonists
12/04/2012US8324216 Substituted piperazines
12/04/2012US8324214 1,3-dihydro-2H-pyrrolo[3,2-bpyridin-2-one derivatives, preparation thereof and therapeutic uses thereof
12/04/2012US8324213 Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulators
12/04/2012US8324212 Compounds for the treatment of hepatitis C
12/04/2012US8324211 6-Dimethylamino-2-(2-hydroxymethyl-3-{8-[5-(morpholine-4-carbonyl)-pyridin-2-ylamino]-imidazo[1,2-b]pyridazin-6-yl }-phenyl)-3,4-dihydro-2H-isoquinolin-1-one; asthma, lupus ; inhibit Btk
12/04/2012US8324210 Pterin analogs
12/04/2012US8324208 Prolyl hydroxylase inhibitors
12/04/2012US8324207 Modulators of ATP-binding cassette transporters
12/04/2012US8324206 Pharmaceutical compounds
12/04/2012US8324205 Quinazoline derivatives as kinase inhibitors
12/04/2012US8324204 Fused thiophene derivatives as kinase inhibitors
12/04/2012US8324203 Azadecalin glucocorticoid receptor modulators
12/04/2012US8324202 5-phenyl-1H-benzo [E] [1,4] diazepine compounds substituted with an hydroxamic acid group as histone deacetylase inhibitors
12/04/2012US8324201 Pyrazinooxazepine derivatives
12/04/2012US8324200 Compositions and methods for inhibition of the JAK pathway
12/04/2012US8324199 Pyridazine derivatives as factor xia inhibitors
12/04/2012US8324198 Monocarbams
12/04/2012US8324197 Transplatinum complexes with N2O2 donor sets as cytotoxic and antitumor agents
12/04/2012US8324196 Polyquinoline derivatives and the therapeutic use thereof
12/04/2012US8324195 Methods of treating hypertriglyceridemia
12/04/2012US8324194 Combination therapy for the treatment of cancer
12/04/2012US8324193 Methods and devices for delivery of compositions to conduits
12/04/2012US8324192 Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
12/04/2012US8324190 Treatment of proliferative disorders with amino-substituted (E)-2,6- dialkoxystyryl 4-substituted benzylsulfones
12/04/2012US8324189 Use of zolendronate for the manufacture of a medicament for the treatment of bone metabolism diseases
12/04/2012US8324188 Combinations of ET-18-O-CH3and anti-cancer agents for the treatment of cancer
12/04/2012US8324187 Stabilized formulations of phosphatidylserine
12/04/2012US8324186 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of CCR2
12/04/2012US8324184 Anti-adhesion composites and methods of use thereof
12/04/2012US8324181 Modulation of gene expression by oligomers targeted to chromosomal DNA
12/04/2012US8324180 Compositions and methods for treating cancer
12/04/2012US8324179 Nucleoside analogs for antiviral treatment
1 ... 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 ... 7860